Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease.

Item

http://www.wikidata.org/entity/Q40366614

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease.

@en

type

Item

label

Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease.

@en

prefLabel

Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease.

@en

P1476

Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease

@en

P2093

Ken H Young

http://www.w3.org/2001/XMLSchema#string

L Jeffrey Medeiros

http://www.w3.org/2001/XMLSchema#string

Li Yu

http://www.w3.org/2001/XMLSchema#string

Mary A Akosile

http://www.w3.org/2001/XMLSchema#string

Meifeng Tu

http://www.w3.org/2001/XMLSchema#string

Prajwal C Boddu

http://www.w3.org/2001/XMLSchema#string

Robert Yarchoan

http://www.w3.org/2001/XMLSchema#string

Roberto N Miranda

http://www.w3.org/2001/XMLSchema#string

Sattva Neelapu

http://www.w3.org/2001/XMLSchema#string

Thomas S Uldrick

http://www.w3.org/2001/XMLSchema#string

P2860

FDA approval: siltuximab for the treatment of patients with multicentric Castleman disease

Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease.

HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy.

Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial.

Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease.

Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease

Successful treatment of Castleman's disease with interleukin-1 receptor antagonist (Anakinra).

Castleman's disease: systematic analysis of 416 patients from the literature

The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care.

Intensity modulated radiation therapy (IMRT) for the treatment of unicentric Castlemans disease: a case report and review of the use of radiotherapy in the literature.

P304

1658-1668

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2016-11-748855

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

129

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28100459

http://www.w3.org/2001/XMLSchema#string

P932

5364343

http://www.w3.org/2001/XMLSchema#string